Am J Gastroenterol

1. ERMINELLI D, Mangini C, Zarantonello L, Angeli P, et al
   Overt hepatic encephalopathy - more than meets the eye.
   Am J Gastroenterol. 2024 Apr 8. doi: 10.14309/ajg.0000000000002795.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

2. DONG M, Zhang T, Liang X, Cheng X, et al
   Sesamin alleviates lipid accumulation induced by oleic acid via PINK1/Parkin-mediated mitophagy in HepG2 cells.
   Biochem Biophys Res Commun. 2024;708:149815.
   

   >> Share

   
   

   
   BMC Cancer

3. JIANG H, Li B, Wu M, Wang Q, et al
   Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer.
   BMC Cancer. 2024;24:428.
   

   >> Share

   
   
4. TIAN Y, Wang Y, Wen N, Wang S, et al
   Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis.
   BMC Cancer. 2024;24:426.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. SUN F, Liu KC, Ul Ain Q, Lu D, et al
   Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinib.
   BMC Gastroenterol. 2024;24:129.
   

   >> Share

   
   
6. MIRYAN M, Rashid SA, Navashenaq JG, Soleimani D, et al
   Dietary inflammatory index in relation to the progression of hepatic steatosis and liver fibrosis: evaluation by elastography/Fibroscan.
   BMC Gastroenterol. 2024;24:128.
   

   >> Share

   
   

   
   Br J Surg

7. KRUL MF, Kok NFM, Osmani H, Buisman FE, et al
   Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
   Br J Surg. 2024;111:znae089.
   

   >> Share

   
   

   
   Clin Res Hepatol Gastroenterol

8. JI J, Zhang Z, Hou Z, Qiu G, et al
   Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with tyrosine kinase inhibitors (TKIs) in patients with unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis.
   Clin Res Hepatol Gastroenterol. 2024;48:102313.
   

   >> Share

   
   
9. ORUC M, Gedik ME, Uner M, Ulug E, et al
   Effectiveness of metformin for the reversal of cold-ischemia-induced damage in hepatosteatosis.
   Clin Res Hepatol Gastroenterol. 2024;48:102314.
   

   >> Share

   
   
10. LI Y, Guo Y, Tan S
    Independent and joint association of physical activity and adequate weekday sleep duration with metabolic dysfunction-associated steatotic liver disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102320.
    

    >> Share

    
    

    
    Dig Dis

11. TEUFEL A, Kudo M, Qian Y, Daza J, et al
    Current Trends and Advancements in the Management of Hepatocellular Carcinoma.
    Dig Dis. 2024 Apr 10. doi: 10.1159/000538815.
    

    >> Share

    
    

    
    Endoscopy

12. OKUNO N, Hara K, Haba S, Kuwahara T, et al
    Endoscopic ultrasound-guided vascular intervention for pancreaticojejunal variceal bleeding.
    Endoscopy. 2024;56.
    

    >> Share

    
    
13. TANISAKA Y, Mizuide M, Fujita A, Shin T, et al
    Successful cannulation using a novel rotatable sphincterotome in a hepaticojejunal anastomotic stricture with a steep angle.
    Endoscopy. 2024;56.
    

    >> Share

    
    

    
    Gut

14. ARMANDI A, Sanavia T, Younes R, Caviglia GP, et al
    Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
    Gut. 2024;73:825-834.
    

    >> Share

    
    
15. WESTER A, Shang Y, Toresson Grip E, Matthews AA, et al
    Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes.
    Gut. 2024;73:835-843.
    

    >> Share

    
    
16. LIU B, Peng G, Yin Y, Shen C, et al
    Genetic evidence for repurposing of glucagon-like peptide-1 receptor agonists to prevent chronic liver diseases.
    Gut. 2024;73:879-882.
    

    >> Share

    
    
17. SUISSA S, Hernaez R
    Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity?
    Gut. 2024;73:721-724.
    

    >> Share

    
    

    
    Hepatology

18. MOGHE A, McGuire BM, Levy C
    Acute hepatic porphyrias - a guide for Hepatologists.
    Hepatology. 2024 Apr 12. doi: 10.1097/HEP.0000000000000880.
    

    >> Share

    
    

    
    J Comput Assist Tomogr

19. ZANDIEH G, Yazdaninia I, Afyouni S, Shaghaghi M, et al
    Spectrum of Imaging Findings and Complications After Hepatic Transarterial Chemoembolization for Liver Tumors.
    J Comput Assist Tomogr. 2024 Apr 10. doi: 10.1097/RCT.0000000000001610.
    

    >> Share

    
    
20. JIANG T, Hu Y, Wang J, Li W, et al
    Fat-Poor Hepatic Angiomyolipoma in Noncirrhotic Livers: Imaging Features, Pathology, and Differential Diagnosis.
    J Comput Assist Tomogr. 2024 Apr 10. doi: 10.1097/RCT.0000000000001605.
    

    >> Share

    
    

    
    J Gastroenterol

21. FUJIWARA K, Kondo T, Fujimoto K, Yumita S, et al
    Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.
    J Gastroenterol. 2024 Apr 7. doi: 10.1007/s00535-024-02097.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

22. OHAMA H, Hiraoka A, Tada T, Kariyama K, et al
    Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct-acting antiviral agents.
    J Gastroenterol Hepatol. 2024 Apr 11. doi: 10.1111/jgh.16553.
    

    >> Share

    
    

    
    J Hepatol

23. CHEN VL, Du X, Oliveri A, Chen Y, et al
    Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort.
    J Hepatol. 2024 Apr 4:S0168-8278(24)00230-7. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
24. YIN K, Buttner M, Deligiannis IK, Strzelecki M, et al
    Polyploidisation pleiotropically buffers ageing in hepatocytes.
    J Hepatol. 2024 Apr 5:S0168-8278(24)00227-7. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
25. CHEN K, Wang Y, Yang J, Kloting N, et al
    EMC10 modulates hepatic ER stress and steatosis in an isoform specific manner.
    J Hepatol. 2024 Apr 8:S0168-8278(24)00234-4. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    

    
    Minerva Gastroenterol (Torino)

26. WANG G, Lu M, Jia H
    Curcumin inhibits liver cancer by regulating Bcl-9/beta-catenin pathway.
    Minerva Gastroenterol (Torino). 2024;70:137-139.
    

    >> Share

    
    
27. HU Z, Liu Y, Jiang J, Hu W, et al
    Clinical study of HAIC via left distal branchial radial artery route in the treatment of liver tumors.
    Minerva Gastroenterol (Torino). 2024;70:128-131.
    

    >> Share

    
    
28. SUN L, Zhao X, Zhang H, Li G, et al
    Relationship between STAP1 methylation in peripheral blood T cells and the clinicopathological characteristics and prognosis of patients within 5-cm diameter HCC.
    Minerva Gastroenterol (Torino). 2024;70:16-21.
    

    >> Share

    
    

    
    PLoS One

29. ZHANG H, Cheng X, Guo W, Zheng C, et al
    Metastasis patterns and prognosis in young gastric cancer patients: A propensity score?matched SEER database analysis.
    PLoS One. 2024;19:e0301834.
    

    >> Share

    
    
30. STAUFFER WT, Bobardt M, Ure DR, Foster RT, et al
    Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH.
    PLoS One. 2024;19:e0301711.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

31. PENG G, Huang XY, Wang YN, Cao XJ, et al
    Prognostic Value of Preoperative MRI-derived 3D Quantitative Tumor Arterial Burden in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization.
    Radiol Imaging Cancer. 2024;6:e230167.
    

    >> Share

    
    
32. COSTA AF, McInnes MDF, van der Pol CB, Lam E, et al
    Individual Participant Data Meta-Analyses for Diagnostic Accuracy Research: Challenges and Lessons Learned from the LI-RADS IPD Group.
    Radiol Imaging Cancer. 2024;6:e240015.
    

    >> Share

    
    

    
    Radiology

33. LEE Y, Kim NH, Kang JH, Cho YS, et al
    Validation of Diagnostic Thresholds for Compensated Advanced Chronic Liver Disease Using Supersonic Shear Imaging.
    Radiology. 2024;311:e232188.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share